Elevated CAIX expression is associated with an increased risk of distant failure in early-stage cervical cancer

Biomarker Insights

Volumn 2008, Issue 3, 2008, Pages 45-55

  Kirkpatrick, John P ^a   Rabbani, Zahid N ^a   Bentley, Rex C ^a   Hardee, Matt E ^a   Karol, Seth ^a   Meyer, Jeffrey ^a   Oosterwijk, Egbert ^b   Havrilesky, Laura ^a   Secord, Angeles Alvarez ^a   Vujaskovic, Zeljko ^a   Dewhirst, Mark W ^a   Jones, Ellen L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Carbonic anhydrase IX; Tumour hypoxia; Uterine cervical cancer

Indexed keywords

CARBONATE DEHYDRATASE IX;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; ENZYME ANALYSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN EXPRESSION; RADICAL HYSTERECTOMY; RECURRENCE RISK; RECURRENT CANCER; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER;

EID: 39549085348     PISSN: None     EISSN: 11772719     Source Type: Journal    
DOI: 10.4137/bmi.s570     Document Type: Article

References (48)

1. Airley, R.E., Loncaster, J., Raleigh, J.A. et al. 2003. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. International Journal of Cancer, 104:85-91.
2. Bedford, J.S. and Mitchell, J.B. 1974. The effect of hypoxia and radiation response of mammalian cells in culture. British Journal of Radiology, 47(562):687-696.
3. Blancher, C. and Harris, A.L. 1998. The molecular basis of the hypoxia response pathway: tumour hypoxia as, a therapy target. Cancer Metastasis Reviews, 17(2):187-194.
4. Brizel, D.M., Scully, S.P., Harrelson, J.M. et al. 1996. Radiation therapy and hyperthermia improve the oxygenation of soft tissue sarcomas. Cancer Research, 56:5347-50.
5. Brizel, D.M., Sibley, G.S., Prosnitz, L.R. et al: 1997. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck International Journal of Radiation Oncology, Biology and Physics, 38:285-9.
6. Brown, J.M. and Le, Q.T. 2002, Tumor hypoxia is important in radiotherapy, but how should we measure it? International Journal of Radiation Oncology, Biology and Physics, 54:1299-301.
7. Cline, J.M., Rosner, G.L., Raleigh, J.A. and Thrall, D.E. 1997. Quantification of CCI-103F labeling heterogeneity in canine solid tumors. International Journal of Radiation Oncology, Biology, Physics, 37:655-62.
8. Coleman, C.N., Mitchell, J.B. and Camphausen, K. 2002. Tumor hypoxia: chicken, egg, or, a piece of the farm? Journal Clinical. Oncology, 20:610-5.
9. Cox, D. 1972. Regression models and life tables. Journal of the Royal Statistical Society B., 34:167-220.
10. Dachs, G.U. and-Chaplin, D.J. 1998. Microenvironmental control of gene expression: implications for tumor angiogonesis, progression and metastases. Seminars in Radiation Oncology, 8:208-16.
11. Dische, S., Anderson, P.J., Scaley, R. and Watson, E.R. 1983. Carcinoma of the cervix - anemia, radiotherapy and hyperbaric oxygen. British Journal of Radiology, 56: 251-5.
12. Evans, S.M., Hahn, S., Pook, D.R. et al. 2000. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Research, 60:2018-24.
13. Fein, D.A., Lee, W.R., Hanlon, A.L. et al. 1995. Pretreatment hemoglobin level influences local control and survival of T1-T2 squambus cell carcinomas of the glottic larynx. Journal of Clinical Oncology, 13:2077-83.
14. Fyles, A., Milosevic, M. and Hedley, D. 2002. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. Journal of Clinical Oncology, 20:680-7.
15. Giatromanolaki, A., Koukourakis, M.I. Sivridis, E, et al 2001. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung-cancer. Cancer Research, 61:7992-8.
16. Graeber, T.G., Osmanian, C., Jacks, T. et al. 1996. Hypoxia-mediated cells with diminished apoptotic potential in solid tumours. Nature, 379:88-91.
17. Gray, L.H., Conger, A.D. and Ebert, M. 1953. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radio-therapy. British Journal of Radiology, 26:638-48.
18. Harris, A.L. 2002. Hypoxia - a key regullatory factor in tumour growth. Nature Reviews Cancer, 2:38-47.
19. Hedley, D., Pintilie, M., Woo, J. et al. 2003. Carbonic anhydrase IX expression, hypoxia and prognosis in patients with uterine cervical carcinoma Clinical Cancer Research, 9:5666-74.
20. Ho, C.M., Chien, T.Y., Huang, S.H. et al. 2004. Multivariate analysis of the prognostic factors and outcomes early cervical cancer patiens under-going radical hysterectomy. Gynecologic Oncology, 91:458-64.
21. Höckel, M., Schlenger, K, Aral, B. et al. 1996. Association between tumor hypoxia and malignant progression in advanced cancer of uterine cervix. Cancer Research, 56:4509-15.
22. Höckel, M., Schlenger, K., Höckel, S. and Vaupel, P. 1999. Hypoxic tumors with low apoptotic index are highly aggressive. Cancer Research, 59:4525-28.
23. Hutchison, G.J., Valentine, H.R., Loncaster, J.A. et al. 2004. Hypoxia-inducible factor 1 alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements and outcome in locally advanced carcinoma of the cervix. Clinical Cancer Research, 10:8405-12.
24. Ivanov, S.V., Kuzmin, I., Wei, M.H. et al. 1998. Down-regulation.of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proceeding of National Academy Science U.S.A., 95:12596-601.
25. Jankovic, B., Aquino-Parsons, C., Raleigh, J.A. et al. 2006. Comparison between pimonidazole binding, oxygen electrode measurements and expression of endogenous hypoxia markers in cancer of the uterine cervix. Cytometry B. Clinical Cytometry, 70:45-55.
26. Kaanders, J.H., Wijffels, K.I., Marres, H.A. et al. 2002. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Research, 62:7066-74.
27. Kaplan, L. and Meier, P. 1958. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53:457-81.
28. Kim, J.Y., Shin, H.J., Kim, T.H., Cho, K.H., Shin, K.H., Kim, B.K., Roh, J.W., Lee, S., Park, S.Y., Hwang, Y.J. and Han, I.O. 2006. Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer. Journal of Cancer Research and Clinical Oncology, 132:302-8.
29. Kim, S.J., Rabbani, Z.N., Dewhirst, M.W. et al. 2005. Expression of HIF-1α, CAIX, VEGF and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer, 49:325-33.
30. Koukourakis, M.I. Bentzen, S.M., Giatromanolaki, A. et al. 2006. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. Journal of Clinical Oncology, 24:727-35.
31. Koukourakis, M.I., Giatromanolaki, A., Sivridis, E. et al. 2001. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clinical, Cancer Research, 7:3399-403.
32. Loncaster, J.A.; Harris, A.L., Davidson, S.E. et al. 2001. Carbonic anhydrase (CAIX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Research, 61:6394-9.
33. Mantel, N. and Haenszel, W. 1958. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 22:718-48.
34. Mayer, A., Hockel, M. and Vaupel, P. 2005. Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally advanced cancers of the uterine cervix. Clinical Cancer Research, 11:7220-5.
35. McKeown, S.R., Coweny, R.L. and Williams, K.J. 2007. Bioreductive drugs: from concept to clinic. Clinical Oncology. (Royal College of Radiologists), 19:427-42.
36. Moon, E.J., Brizel, D.M., Chi, J.T. and Dewhirst, M.W. 2007. The potential role of intrinsic hypoxia markers as prognostic variables in cancer. Antioxidant Redox Signalling, 9:1237-94.
37. Nordsmark, M., Overgaard, M. and Overgaard, J. 1996. Pre-treatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiotherapy and Oncology, 41:31-9.
38. Olive, P.L., Aquino-Parsons, C., MacPhail, S.H. et al. 2001. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Research, 61:8924-9.
39. Opavsky, R., Pastorekova, S., Zelnik, V. et al. 1996. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics, 33:480-7.
40. Rajendran, J.G. and Krohn, K.A. 2005. Imaging hypoxia and angiogenesis in tumors. Radiology Clinics of North America, 43:169-87.
41. Reynolds, T.Y., Rockwell, S. and Glazer, P.M. 1996. Genetic instability induced by the tumor microenvironment. Cancer Research, 56:5754-7.
42. Secomb, T.W., Hsu, R., Braun, R.D. et al. 1998. Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels. Advances in Experimental Medicine and Biology, 454:629-34.
43. Sundfor, K., Lyng, H. and Rofstad, E.K. 1998. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. British Journal of Cancer, 78:822-7.
44. Sutherland, R.M. 1998. Tumor hypoxia and gene expression - implications for malignant progression and therapy. Acta. Oncologica, 37:567-74.
45. Swinson, D.E., Jones, J.L., Richardson, D. et al. 2003. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. Journal of Clinical Oncology, 21:473-82.
46. Vordermark, D. and Brown, J.M. 2003. Endogenous markers of tumor hypoxia - predictors of clinical radiation resistance. Strahlentherapie und Onkologie, 179:801-11.
47. Wykoff, C.C., Beasley, NJP., Watson, P.H. et al. 2000. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Research, 60:2075-85.
48. Yamagata, M., Hasuda, K., Stamato, T. and Tannock, I.F. 1998. The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. British Journal of Cancer, 77:1726-31.